NYSE · ARDT
Ardent Health, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for ARDT: Nov 04, 2026
Ardent Health, Inc. Common Stock is expected to report earnings on 11/04/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 4 analysts' forecasts, the consensus EPS forecast for the quarter is $0.24. The reported EPS for the same quarter last year was $0.52.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $0.24 | $0.31 | $0.13 | 4 |
| Dec 2026 | $0.34 | $0.34 | $0.33 | 3 |
| Mar 2027 | $0.25 | $0.27 | $0.24 | 2 |
| Jun 2027 | $0.31 | $0.34 | $0.27 | 2 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Fintel · Zacks · BNK Invest · The Motley Fool- Fintel · Sep 24, 8:25 AM EDTBMO Capital Initiates Coverage of Ardent Health at Market PerformFintel reports that on September 23, 2026, BMO Capital initiated coverage of Ardent Health (NYSE:ARDT) with a Market Perform recommendation. On the day of the rating action, September 23, 2026, the stock closed at $10.64, compared to a pre-action close of $10.95 on September 22,
- Zacks · Sep 16, 12:01 PM EDTIs the Options Market Predicting a Spike in Ardent Health Stock?Investors need to pay close attention to ARDT stock based on the movements in the options market lately.
- BNK Invest · Sep 1, 12:00 PM EDTTuesday Sector Leaders: Hospital & Medical Practitioners, Cigarettes & Tobacco StocksIn trading on Tuesday, hospital & medical practitioners shares were relative leaders, up on the day by about 1.8%. Leading the group were shares of Surgery Partners, up about 6.2% and shares of Ardent Health up about 3.8% on the day. Also showing relative strength are ciga
- Zacks · Aug 13, 8:46 AM EDTImplied Volatility Surging for Ardent Health Stock OptionsInvestors need to pay close attention to ARDT stock based on the movements in the options market lately.
- The Motley Fool · Aug 11, 7:28 PM EDTArdent Health (ARDT) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Zacks · Aug 7, 4:34 AM EDTNew Strong Sell Stocks for August 7thARDX, ARDT and GPRE have been added to the Zacks Rank #5 (Strong Sell) List on August 7th, 2026.
- MarketBeat · Aug 5, 5:04 PM EDTArdent Health Q2 Earnings Call HighlightsFalling Fast, Rising Soon? 3 Stocks With Upside AheadArdent Health (NYSE:ARDT) reported second-quarter revenue of $1.62 billion and adjusted EBITDA of $115 million, as management said cost controls, a favorable payer contract renewal and strong cash flow helped offset weaker-than
- Zacks · Aug 4, 7:00 PM EDTArdent Health, Inc. (ARDT) Q2 Earnings Lag EstimatesArdent Health, Inc. (ARDT) delivered earnings and revenue surprises of -29.41% and +1.96%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Jul 30, 8:05 AM EDTLabcorp Holdings (LH) Surpasses Q2 Earnings and Revenue EstimatesLabcorp (LH) delivered earnings and revenue surprises of +4.18% and +0.36%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Jul 29, 8:35 PM EDTIcon PLC (ICLR) Lags Q2 Earnings EstimatesIcon PLC (ICLR) delivered earnings and revenue surprises of -0.39% and +3.48%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Jul 29, 10:00 AM EDTCharles River Laboratories (CRL) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 ReleaseCharles River (CRL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks · Jul 28, 10:00 AM EDTArdent Health, Inc. (ARDT) Expected to Beat Earnings Estimates: Should You Buy?Ardent Health, Inc. (ARDT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Ardent Health, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.